Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

7.55
-0.1450-1.88%
Post-market: 7.54-0.0100-0.13%17:27 EDT
Volume:703.93K
Turnover:5.35M
Market Cap:129.49M
PE:-0.60
High:7.79
Open:7.70
Low:7.42
Close:7.70
52wk High:24.49
52wk Low:7.42
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.67
T/O Rate:4.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.58
PE(LYR):-0.52

Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 13

Tonix Rises on Medicare Coverage Expansion for Chronic Pain Treatment

Reuters
·
Jul 13

Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for Tonmya®

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals - Announces Medicare Agreement for Tonmya Adding 9 Mln Lives Effective Jan 1, 2027

THOMSON REUTERS
·
Jul 13

Tonix Pharmaceuticals Posts Investor Deck Spotlighting Tonmya Fibromyalgia Launch Strategy

Reuters
·
Jul 08

Analysts’ Top Healthcare Picks: Tonix Pharma (TNXP), Carlsmed, Inc. (CARL)

TIPRANKS
·
Jul 01

Tonix Pharmaceuticals - Enrolls First Patient in Phase 2 Horizon Study of Tnx-102 Sl for Mdd - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Pharmaceuticals - Primary Endpoint is Change in Madrs Total Score at Week 6 - SEC Filing

THOMSON REUTERS
·
Jun 29

Tonix Enrolls First Patient in Phase 2 Trial of Tnx-102 SL for Major Depressive Disorder

Reuters
·
Jun 29

Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts

TIPRANKS
·
Jun 27

Tonix Pharmaceuticals initiated with a Strong Buy at Raymond James

TIPRANKS
·
Jun 25

Tonix Pharmaceuticals publishes investor deck focused on TONMYA fibromyalgia launch and pipeline programs

Reuters
·
Jun 16

Tonix Pharma director Carolyn E. Taylor acquires 1,415 shares worth $14,928.25

Reuters
·
Jun 15

Tonix Pharma management to join BTIG Infectious Disease Day 1x1 meetings

Reuters
·
Jun 11

Tonix Pharma director Richard Newcomb Stillwell acquires 5,000 shares for $58,250

Reuters
·
Jun 10

Tonix Pharmaceuticals Enters Second Commercial Payer Deal, Expands Drug Coverage

MT Newswires Live
·
Jun 08

Tonix Pharmaceuticals secures second commercial agreement for Tonmya

TIPRANKS
·
Jun 08

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for Tonmya®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

THOMSON REUTERS
·
Jun 08

Tonix shares TNX-4800 Lyme disease prevention presentation

Reuters
·
Jun 01

Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch, pipeline updates

Reuters
·
Jun 01